Meera Gurumurthy

QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial

Gareth Hughes, Elena Frangou, Henry Bern, Meera Gurumurthy et autres

gb, mn, fr, tw (code pays fourni par la source)

QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial

Gareth Hughes, Eleni Frangou, Henry Bern, Meera Gurumurthy et autres

gb, mn, fr, tw (code pays fourni par la source)

The role of stakeholder mapping and engagement in Mongolia during the implementation of the STREAM clinical trial for MDR-TB

Bazarragchaa Tsogt, Meera Gurumurthy, Elisa Giallongo, Karen Sanders et autres

mn, gb, us (code pays fourni par la source)

Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial

Meera Gurumurthy, Gopalan Narendran, Leena Patel, A. Davis et autres

in, us, gb, Afrique du Sud (code pays fourni par la source)

Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Andrew Nunn, Sarah Meredith, Adamu Bayissa et autres

gb, Éthiopie, fr, tw, Afrique du Sud, in, us, Ouganda, ge, be, mn, md (code pays fourni par la source)

Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis

Stella M. Fabiane, Chen‐Yuan Chiang, Sarah Meredith, Meera Gurumurthy et autres

gb, tw, Éthiopie (code pays fourni par la source)

Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial

Nicholas I. Paton, Meera Gurumurthy, Qingshu Lu, Francesca Leek et autres

sg, gb, ph, my (code pays fourni par la source)

Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research

Kalpita Shringarpure, Meera Gurumurthy, Karuna D. Sagili, Melissa Taylor et autres

in, gb, ch (code pays fourni par la source)

Implementation challenges and lessons learned from the STREAM clinical trial—a survey of trial sites

Leena Patel, Meera Gurumurthy, Gay Bronson, Karen Sanders et autres

us, gb (code pays fourni par la source)

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn, Adamu Bayissa et autres

mn, Afrique du Sud, gb, md, in, be, Éthiopie, us, fr, Ouganda, ge (code pays fourni par la source)

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis

Ruth Goodall, Karen Sanders, Gay Bronson, Meera Gurumurthy et autres

gb, us, be (code pays fourni par la source)

Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model

Claire M. Naftalin, Rupangi Verma, Meera Gurumurthy, Qingshu Lu et autres